IMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results

Bulletin Express

Aug 19

IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The company also intends to authorize the public release of these results following board approval.

The current board structure comprises: • Executive Directors: Dr. Sui Xiong Cai (also Chief Executive Officer), Dr. Ye Edward Tian and Ms. Ning Ma • Non-Executive Directors: Dr. Cong Xu, Dr. Qiang Xu and Mr. Tao Liu • Independent Non-Executive Directors: Dr. Edward Ming Guo, Mr. Chi Hung Siu and Dr. Liming Shao

The announcement was issued in Hong Kong on 19 August 2026 and signed by Executive Director and CEO Dr. Sui Xiong Cai.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1122709213"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122709213\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122709213?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-19 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122709213","market":"us","top_or_hot":-1,"title":"IMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results","media":"Bulletin Express","content":"<p>IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The company also intends to authorize the public release of these results following board approval.</p>\n<p>The current board structure comprises:\n• Executive Directors: Dr. Sui Xiong Cai (also Chief Executive Officer), Dr. Ye Edward Tian and Ms. Ning Ma  \n• Non-Executive Directors: Dr. Cong Xu, Dr. Qiang Xu and Mr. Tao Liu  \n• Independent Non-Executive Directors: Dr. Edward Ming Guo, Mr. Chi Hung Siu and Dr. Liming Shao</p>\n<p>The announcement was issued in Hong Kong on 19 August 2026 and signed by Executive Director and CEO Dr. Sui Xiong Cai.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-19 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The company also intends to authorize the public release of these results following board approval.</p>\n<p>The current board structure comprises:\n• Executive Directors: Dr. Sui Xiong Cai (also Chief Executive Officer), Dr. Ye Edward Tian and Ms. Ning Ma  \n• Non-Executive Directors: Dr. Cong Xu, Dr. Qiang Xu and Mr. Tao Liu  \n• Independent Non-Executive Directors: Dr. Edward Ming Guo, Mr. Chi Hung Siu and Dr. Liming Shao</p>\n<p>The announcement was issued in Hong Kong on 19 August 2026 and signed by Executive Director and CEO Dr. Sui Xiong Cai.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07630","symbol_name":"英派药业-B","start_time":0,"source_url":"","article_id":"1122709213","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122709213","pubTimestamp":1787129230,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07630":"英派药业-B"},"translate_title":"IMPACT Therapeutics 定于 2026 年 8 月 31 日召开董事会会议，批准 2026 年上半年未经审计业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07630":1},"content_text":"IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The company also intends to authorize the public release of these results following board approval.\nThe current board structure comprises:\n• Executive Directors: Dr. Sui Xiong Cai (also Chief Executive Officer), Dr. Ye Edward Tian and Ms. Ning Ma  \n• Non-Executive Directors: Dr. Cong Xu, Dr. Qiang Xu and Mr. Tao Liu  \n• Independent Non-Executive Directors: Dr. Edward Ming Guo, Mr. Chi Hung Siu and Dr. Liming Shao\nThe announcement was issued in Hong Kong on 19 August 2026 and signed by Executive Director and CEO Dr. Sui Xiong Cai.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}